Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasushi Yoshimura

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Oncology Reports|January 5, 2006
Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft modelsShigeto Kawai, Yasushi Yoshimura, Shin-Ichiro Iida, et al.
Leukemia Research|February 24, 2005
Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myelomaYasufumi Kikuchi, Shinsuke Uno, Yasuko Kinoshita, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2019
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugateYoriko Yamashita-Kashima, Yasushi Yoshimura, Takaaki Fujimura, et al.
Thrombosis Journal|June 28, 2023
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational studyRyohei Kawasaki, Asuka Sakata, Chihiro Hosoda, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2021
Detailed analysis of anti-emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia AMakoto Kaneda, Ryohei Kawasaki, Naoki Matsumoto, et al.
Scientific Reports|November 29, 2024
β-hydroxybutyrate suppresses pathological changes of blood-induced arthropathy in ratsRyohei Kawasaki, Asuka Sakata, Kohei Tatsumi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 20, 2024
Force-sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathyYuya Mawarikado, Asuka Sakata, Yusuke Inagaki, et al.
Molecular Cancer Therapeutics|March 29, 2020
Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance ModelTomoko Funazo, Takahiro Tsuji, Hiroaki Ozasa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutationsHiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura, et al.
EJNMMI Research|June 28, 2015
Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approachesTetyana Tegnebratt, Elisabeth Ruge, Sabine Bader, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Oncology Reports|January 5, 2006
Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft modelsShigeto Kawai, Yasushi Yoshimura, Shin-Ichiro Iida, et al.
Leukemia Research|February 24, 2005
Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myelomaYasufumi Kikuchi, Shinsuke Uno, Yasuko Kinoshita, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2019
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugateYoriko Yamashita-Kashima, Yasushi Yoshimura, Takaaki Fujimura, et al.
Thrombosis Journal|June 28, 2023
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational studyRyohei Kawasaki, Asuka Sakata, Chihiro Hosoda, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2021
Detailed analysis of anti-emicizumab antibody decreasing drug efficacy, using plasma samples from a patient with hemophilia AMakoto Kaneda, Ryohei Kawasaki, Naoki Matsumoto, et al.
Scientific Reports|November 29, 2024
β-hydroxybutyrate suppresses pathological changes of blood-induced arthropathy in ratsRyohei Kawasaki, Asuka Sakata, Kohei Tatsumi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 20, 2024
Force-sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathyYuya Mawarikado, Asuka Sakata, Yusuke Inagaki, et al.
Molecular Cancer Therapeutics|March 29, 2020
Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance ModelTomoko Funazo, Takahiro Tsuji, Hiroaki Ozasa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutationsHiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura, et al.
EJNMMI Research|June 28, 2015
Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approachesTetyana Tegnebratt, Elisabeth Ruge, Sabine Bader, et al.
Pageof 4